medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2010, Number 4

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2010; 8 (4)

Scleredema of Buschke. A review

Baños C, Valencia C, Rodríguez ZNJ, Cerón EJD, Cetina AW, Vargas MF, Arenas R, Vega MME

Language: Spanish
References: 30
Page: 262-269
PDF size: 644.62 Kb.


ABSTRACT

Scleredema of Buschke is a connective tissue disease of unknown etiology, characterized by an excess of dermal acid mucopolysaccharides. It is considered an adult disease, but can also occur in children. Clinically it may be preceded by an acute febrile illness, usually infectious. The onset is insidious and gradual, beginning in the neck and spreads to face, shoulder, upper trunk, and arms, producing a diffuse and symmetrical induration of the skin, without edema, with a normal color and woody like on palpation and usually asymptomatic. The differential diagnosis must be made with scleroderma, dermatomyositis, rheumatic fever and other widespread indurations of the skin.


REFERENCES

  1. Basavaraj K, Prakash B. “Escleredema of Buschke”. Ind J Dermatol 1996; 41(3): 102-103.

  2. Tamburin L, Pena J, Meredith R, et al. “Scleredema of Buschke successfully treated with electron beam therapy”. Arch Dermatol 1998; 134: 419-422.

  3. Banney L, Weedon D, Muir J. “Nuchal fibroma associated with scleredema, diabetes mellitus and organic solvent exposure”. Austr J Dermatol 2000; 41: 39-41.

  4. Alp H. Orbak Z. Aktaij A. “Scleredema adultorum due to streptococcal infection”. Pediatrics Int 2003; 45: 101-103.

  5. Dereme O, Dandurand M, Barneon G, et al. “Escleredema de Buschke en una diabética”. Ann Dermatol Venereol 1992; 119: 559-561.

  6. Roccatagliata G, Maris S, Alba J, et al. “Escleredema adultorum de Buschke y carditis”. Arch Argent Pediatr 2000; 98(2): 116.

  7. Curtis A. “Scleredema adultorum: not always a benign self-limited disease”. Arch Dermat 1965; 92: 526-40.

  8. Vallee BL. “Scleredema: A systemic disease”. N Engl J Med 1946; 235: 207-213.

  9. Hwang J, Cho K, Park K, et al. “A case of congenital scleredema”. Clin Exp Dermatol 1998; 23: 138-144.

  10. Cole HG, Winkelmann RK. “Acid mucopolysaccharide staining in scleredema”. J Cutan Pathol 1990; 17: 211-13.

  11. Bowen A, Smith L, Zone J. “Scleredema adultorum of Buschke treated with radiation”. Arch Dermatol 2003; 139: 780-784.

  12. Garaguso G, Hidalgo I, Galimberti G, et al. “Escleredema diabético. Presentación de un caso y revisión de literatura”. Dermatol Arg 2006; 12(4): 292-293.

  13. Lewerenz V, Ruzicka T. “Scleredema adultorum associated with type 2 diabetes mellitus: a report of three cases”. Eur Acad Dermatol Venereol 2007; 21: 560-561.

  14. Rao S, Kar R, Pati H, et al. “Scleredema-associated IgA myeloma with myelofibrosis in a young adult: a case report”. Turk J Hematol 2008; 25: 195-197.

  15. Fleischmajer R, Perlish J. “Glycosaminogllycans in scleroderma and scleredema”. J Invest Dermatol 1972; 58: 3.

  16. Engin B, Mat M, Demirkesen C, et al. “Scleredema adultorum associated with hyperkeratosis”. Pediatr Dermatol 2005; 22(1): 36-39.

  17. Ruiz F, Kuriokose R, Deleu D, et al. “Scleredema diabeticorum with unusual presentation and fatal outcome”. Indian J Dermatol 2008; 53(4): 217-219.

  18. Wang H. Ho C. Ark P, et al. “A case of congenital scleredema”. Clin Exp Dennatol 1998; 23: 134-140.

  19. Tavera M. “Piel, desnutrición y enfermedad digestiva”. Dermatol PediatrLat 2007; 5(2): 88.

  20. Morrell DS, Challgren E, Nijhawan A, et al. “Two cases for diagnosis: Asymmetric childhood scleredema or stiff skin syndrome?” Ped Dermatol 2003; 20; 350-355.

  21. Hodak E, Tamir R, Davi M, et al. “Scleredema adultorum associated with IgG-kappa multiple myeloma”. Clin Exp Dermatol 1988; 13: 271-274.

  22. Cunha A, Azulay D. “Enfermedades metabólicas e histiocíticas de interés dermatológico”. En: Azulay RD, Azular DR, Azulay-Abulafia L. Dermatología, 4ta ed. Río de Janeiro, Guanabara Koogan 2006; 482-483.

  23. Grudeva-Popova J, Dobrev H. “Biomechanical measurement of skin distensibility in scleredema of Buschke associated with multiple myeloma”. Clin Exp Dermatol 2000; 25: 247-249.

  24. Santos-Juanes J, Galache Osuna C, Iglesias C. “Treatment with chemotherapy of scleredema associated with Ig A myeloma”. Int J Dermatol 2001; 40: 720-721.

  25. Miyagawa S, Dohi K, Tsuruta S, et al. “Scleredema of Buschke associated with rheumatoid arthritis and Sjögren’s syndrome”. Br J Dermatol 1989; 121: 517-520.

  26. Okuyama R, Tagami H. “Scleredema adultorum associated with anaphylactoid purpura”. Acta Derm Venereol 1997; 77; 159-161.

  27. Ratip S, Akin H, Ozdemirli M, et al. “Scleredema of Buschke associated with Waldenström´s macroglobulinaemia”. Br J Dermatol 2000; 143: 450-452.

  28. Toyota T, Umezu M, Oikawa N, et al. “Diabetic Scleredema”. Tohoku J Exp Med 1983; 141: 457-461.

  29. Eberlein-König B, Vogel M, Katzer K, et al. “Successful UVA1 phototherapy in a patient with scleredema adultorum”. JEADV 2005; 19: 203- 204.

  30. Janiga J, Ward D, Lim H. “UVA-1 as a treatment for scleredema”. Photodermatol Photoimmunol Photomed 2004; 20: 210-211.




2020     |     www.medigraphic.com